ALKBH1 contributes to renal cell carcinoma progression by reducing N6-methyladenine of GPR137.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of clinical investigation"
DOI: 10.1111/eci.13986
Abstract: Renal cell carcinoma (RCC) accounts for approximately 4% of all the adult malignancies with the high mortality worldwide. Although conventional chemotherapy and radiotherapy treatment has been applied for RCC in clinic, the mortality rate of… read more here.
Keywords: cell; gpr137; cell carcinoma; renal cell ... See more keywords